Archive (english)

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

NEW ON THE MARKET

Clesrovimab (ENFLONSIA) for prevention of respiratory syncytial virus (RSV) disease in infants

Atogepant (AQUIPTA) now also for acute migraine attacks

THERAPY FROM A CRITICAL VIEWPOINT

Influenza vaccination in older adults: adjuvanted vaccine (FLUAD) versus high-dose vaccine (EFLUELDA)

a-t READERS QUESTIONS AND COMMENTS

On the duration of treatment with denosumab (PROLIA, biosimilars) for osteoporosis

Antithrombotic treatment for patients with peripheral arterial disease plus atrial fibrillation

IN BRIEF

New flu vaccines for the 2026/27 season

Isotretinoin (e.g. AKNENORMIN) is no cosmetic!

SIDE EFFECTS

Insulin icodec (AWIQLI): caution when switching to daily basal insulin
free

ACE inhibitors: epinephrine (SUPRARENIN, generics) possibly ineffective in case of angioedema

e a-t ON THE INTERNET

Clesrovimab (ENFLONSIA) for prevention of respiratory syncytial virus (RSV) disease in infants (long version)

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles